XM does not provide services to residents of the United States of America.

EU 2024/25 soybean imports up 9% by Nov 17, rapeseed up 16%



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-EU 2024/25 soybean imports up 9% by Nov 17, rapeseed up 16%</title></head><body>

Adds year-on-year variations, background and main countries for imports

Nov 19 (Reuters) -European Union soybean imports so far in the 2024/25 season that started in July had reached 4.75 million metric tons by Nov. 17, up 9% compared with 4.36 million tons a year earlier, data published by the European Commission showed on Tuesday.

EU rapeseed imports in the same period totalled 2.34 million tons, up 16% from 2.02 million a year earlier, while soymeal imports reached 7.08 million tons, 23% above the 5.76 million imported by the same time the previous year.

EU palm oil imports were at 1.22 million tons, down 16% against from 1.45 million tons a year earlier.

The main supplier countries for EU soybean, rapeseed, soymeal and palm oil imports were given as follows:


SOYBEAN IMPORTS

2024/25


2023/24


Origin

tons

share


tons

share

Brazil

2,394,953

50.4%


1,733,832

39.7%

USA

1,752,517

36.9%


1,910,488

43.8%

Ukraine

418,161

8.8%


329,453

7.5%

Canada

146,094

3.1%


185,696

4.3%

Togo

17,988

0.4%


29,587

0.7%


RAPESEED IMPORTS

2024/25


2023/24


Origin

tons

share


tons

share

Ukraine

1,634,544

70.0%


1,293,301

64.1%

Australia

474,053

20.3%


366,915

18.2%

Moldova

74,656

3.2%


210,821

10.4%

Canada

67,529

2.9%


42,447

2.1%

Serbia

39,980

1.7%


86,266

4.3%


SOYMEAL IMPORTS

2024/25

2023/24

Origin

tons

share


tons

share

Brazil

3,545,479

50.1%


3,847,511

66.8%

Argentina

2,739,525

38.7%


1,025,470

17.8%

Ukraine

197,839

2.8%


135,715

2.4%

India

164,434

2.3%


370

0.0%

Paraguay

134,702

1.9%


220,267

3.8%


PALM OIL IMPORTS

2024/25

2023/24

Origin

tons

share


tons

share

Indonesia

391,896

32.2%


485,565

33.5%

Malaysia

259,106

21.3%


348,719

24.1%

Guatemala

163,553

13.4%


228,294

15.8%

Papua New Guinea

119,488

9.8%


83,944

5.8%

Honduras

88,493

7.3%


130,453

9.0%




Reporting by Nathan Vifflin, Olivier Cherfan and Sybille de La Hamaide; Editing by Emelia Sithole-Matarise and David Evans

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.